Notice: Users may be experiencing issues with displaying some pages on stanfordhealthcare.org. We are working closely with our technical teams to resolve the issue as quickly as possible. Thank you for your patience.
Final 5-Year Safety and Efficacy Results Of a Phase 3, Randomized Placebo-Controlled Trial Of Golimumab In Patients With Active Rheumatoid Arthritis Despite Prior Treatment With Methotrexate Keystone, E., Genovese, M. C., Hall, S., Miranda, P., Bae, S., Han, C., Gathany, T. A., Zhou, Y., Xu, S., Hsia, E. C. WILEY-BLACKWELL. 2013: S597–S598
View details for Web of Science ID 000325359203395